Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Diabetes Sci Technol ; 14(3): 679-686, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32174135

RESUMEN

This is a summary report of the most important aspects discussed during the YSI 2300 Analyzer Replacement Meeting. The aim is to provide the interested reader with an overview of the complex topic and propose solutions for the current issue. This solution should not only be adequate for the United States or Europe markets but also for all other countries. The meeting addendum presents three outcomes of the meeting.


Asunto(s)
Análisis Químico de la Sangre/instrumentación , Automonitorización de la Glucosa Sanguínea/instrumentación , Glucemia/análisis , Ácido Láctico/sangre , Biomarcadores/sangre , Análisis Químico de la Sangre/normas , Automonitorización de la Glucosa Sanguínea/normas , Diseño de Equipo , Humanos , Variaciones Dependientes del Observador , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados
2.
J Endocr Soc ; 2(12): 1320-1337, 2018 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-30474069

RESUMEN

The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals with diabetes. CGM systems provide retrospective data, as well as the current glucose value and trend arrow data, which indicate the direction and velocity of changing glucose. In 2017, Aleppo and colleagues developed a simplified approach for adults with diabetes to safely adjust rapid-acting insulin doses using trend arrow information in the Dexcom G5 CGM system. Since then, the FreeStyle Libre and FreeStyle Libre 14-day CGM systems have become available in the United States; however, guidance on using trend arrow data that take the unique features of these systems into consideration is lacking. Specifically, the FreeStyle Libre systems do not have automatic alarms, which impact how the system and trend arrow data are used. The Endocrine Society convened an expert panel to address this gap and develop an approach to adjusting rapid-acting insulin doses for adults using trend arrows in the FreeStyle Libre systems. We based our approach on previous work and expanded upon engagement and scanning recommendations, and we incorporated pre-exercise planning specific to these systems. Our approach provides insulin dose adjustments as discrete insulin units based on an individual's insulin sensitivity and directionality of the trend arrow. We focus on the needs of patients treated with multiple daily injections because these individuals currently make up a greater proportion of individuals on intensive insulin therapy. Our recommendations are intended to provide a safe, practical approach to using trend arrows in the FreeStyle Libre systems.

3.
J Endocr Soc ; 1(12): 1445-1460, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-29344577

RESUMEN

After reviewing previously published methods, we developed a practical approach to adjusting insulin doses based on insulin sensitivity for adult patients with diabetes using rtCGM trend arrow data.

4.
J Endocr Soc ; 1(12): 1461-1476, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-29344578

RESUMEN

After assessing previously published methods, we developed a practical approach to adjusting insulin doses using rtCGM trend arrows in pediatric patients with diabetes.

5.
Cancer Biol Ther ; 13(13): 1319-24, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22895071

RESUMEN

The X-linked deubiquitinase USP9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.


Asunto(s)
Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/genética , Fluorouracilo/farmacología , Ubiquitina Tiolesterasa/genética , Antimetabolitos Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/genética , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/genética , Neoplasias Colorrectales/enzimología , Neoplasias Gastrointestinales/tratamiento farmacológico , Neoplasias Gastrointestinales/genética , Células HCT116 , Humanos , Ubiquitina Tiolesterasa/deficiencia , Ubiquitina Tiolesterasa/metabolismo
7.
J Bacteriol ; 191(16): 5240-52, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19502398

RESUMEN

We have generated extreme ionizing radiation resistance in a relatively sensitive bacterial species, Escherichia coli, by directed evolution. Four populations of Escherichia coli K-12 were derived independently from strain MG1655, with each specifically adapted to survive exposure to high doses of ionizing radiation. D(37) values for strains isolated from two of the populations approached that exhibited by Deinococcus radiodurans. Complete genomic sequencing was carried out on nine purified strains derived from these populations. Clear mutational patterns were observed that both pointed to key underlying mechanisms and guided further characterization of the strains. In these evolved populations, passive genomic protection is not in evidence. Instead, enhanced recombinational DNA repair makes a prominent but probably not exclusive contribution to genome reconstitution. Multiple genes, multiple alleles of some genes, multiple mechanisms, and multiple evolutionary pathways all play a role in the evolutionary acquisition of extreme radiation resistance. Several mutations in the recA gene and a deletion of the e14 prophage both demonstrably contribute to and partially explain the new phenotype. Mutations in additional components of the bacterial recombinational repair system and the replication restart primosome are also prominent, as are mutations in genes involved in cell division, protein turnover, and glutamate transport. At least some evolutionary pathways to extreme radiation resistance are constrained by the temporally ordered appearance of specific alleles.


Asunto(s)
Evolución Molecular Dirigida , Escherichia coli/genética , Escherichia coli/efectos de la radiación , Radiación Ionizante , Cromatografía Líquida de Alta Presión , Electroforesis en Gel de Campo Pulsado , Escherichia coli/crecimiento & desarrollo , Mutación , Filogenia , Rec A Recombinasas/genética , Rec A Recombinasas/fisiología
8.
J Bacteriol ; 190(19): 6475-82, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18676665

RESUMEN

DdrA protein binds to and protects 3' DNA ends and is essential for preserving the genome integrity of Deinococcus radiodurans following treatment by gamma radiation in an environment lacking nutrients. Limited proteolysis was used to identify a stable and functional protein core, designated DdrA157, consisting of the first 157 residues of the protein. In vitro, the biochemical differences between wild-type and mutant proteins were modest. DdrA exhibits a strong bias in binding DNA with 3' extensions but not with 5' extensions. The mutant DdrA157 exhibited a greater affinity for 5' DNA ends but still bound to 3' ends more readily. However, when we replaced the wild-type ddrA gene with the mutant gene for ddrA157, the resulting D. radiodurans strain became almost as sensitive to gamma radiation as the ddrA knockout strain. These results suggest that while the stable protein core DdrA157 is functional for DNA binding and protection assays in vitro, the carboxyl terminus is required for important functions in vivo. The C terminus may therefore be required for protein or DNA interactions or possibly as a regulatory region for DNA binding or activities not yet identified.


Asunto(s)
Proteínas Bacterianas/metabolismo , Proteínas de Unión al ADN/metabolismo , Deinococcus/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/fisiología , Western Blotting , Reparación del ADN , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/fisiología , Deinococcus/genética , Deinococcus/efectos de la radiación , Ensayo de Cambio de Movilidad Electroforética , Rayos gamma , Mutación , Unión Proteica
9.
FEBS J ; 272(5): 1189-200, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15720393

RESUMEN

We have cloned NADH oxidase homologues from Pyrococcus horikoshii and P. furiosus, and purified the recombinant form of the P. horikoshii enzyme to homogeneity from Escherichia coli. Both enzymes (previously referred to as NOX2) have been shown to act as a coenzyme A disulfide reductases (CoADR: CoA-S-S-CoA + NAD(P)H + H+-->2CoA-SH + NAD(P)+). The P. horikoshii enzyme shows a kcat app of 7.2 s(-1) with NADPH at 75 degrees C. While the enzyme shows a preference for NADPH, it is able to use both NADPH and NADH efficiently, with both giving roughly equal kcats, while the Km for NADPH is roughly eightfold lower than that for NADH. The enzyme is specific for the CoA disulfide, and does not show significant reductase activity with other disulfides, including dephospho-CoA. Anaerobic reductive titration of the enzyme with NAD(P)H proceeds in two stages, with an apparent initial reduction of a nonflavin redox center with the first reduction resulting in what appears to be an EH2 form of the enzyme. Addition of a second of NADPH results in the formation of an apparent FAD-NAD(P)H complex. The behavior of this enzyme is quite different from the mesophilic staphylococcal version of the enzyme. This is only the second enzyme with this activity discovered, and the first from a strict anaerobe, an Archaea, or hyperthermophilic source. P. furiosus cells were assayed for small molecular mass thiols and found to contain 0.64 micromol CoA.g dry weight(-1) (corresponding to 210 microM CoA in the cell) consistent with CoA acting as a pool of disulfide reducing equivalents.


Asunto(s)
Coenzima A/metabolismo , ADN de Archaea/metabolismo , NADH NADPH Oxidorreductasas/metabolismo , Pyrococcus horikoshii/enzimología , Secuencia de Aminoácidos , Catálisis , Clonación Molecular , ADN de Archaea/genética , Estabilidad de Enzimas , Flavina-Adenina Dinucleótido/metabolismo , Calor , Concentración de Iones de Hidrógeno , Cinética , Datos de Secuencia Molecular , NAD/metabolismo , NADH NADPH Oxidorreductasas/química , NADH NADPH Oxidorreductasas/genética , NADP/metabolismo , Oxidación-Reducción , Homología de Secuencia de Aminoácido , Compuestos de Sulfhidrilo/metabolismo
10.
PLoS Biol ; 2(10): e304, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15361932

RESUMEN

The bacterium Deinococcus radiodurans can withstand extraordinary levels of ionizing radiation, reflecting an equally extraordinary capacity for DNA repair. The hypothetical gene product DR0423 has been implicated in the recovery of this organism from DNA damage, indicating that this protein is a novel component of the D. radiodurans DNA repair system. DR0423 is a homologue of the eukaryotic Rad52 protein. Following exposure to ionizing radiation, DR0423 expression is induced relative to an untreated control, and strains carrying a deletion of the DR0423 gene exhibit increased sensitivity to ionizing radiation. When recovering from ionizing-radiation-induced DNA damage in the absence of nutrients, wild-type D. radiodurans reassembles its genome while the mutant lacking DR0423 function does not. In vitro, the purified DR0423 protein binds to single-stranded DNA with an apparent affinity for 3' ends, and protects those ends from nuclease degradation. We propose that DR0423 is part of a DNA end-protection system that helps to preserve genome integrity following exposure to ionizing radiation. We designate the DR0423 protein as DNA damage response A protein.


Asunto(s)
Proteínas Bacterianas/fisiología , Proteínas de Unión al ADN/genética , Deinococcus/genética , Regulación Bacteriana de la Expresión Génica , Genoma Bacteriano , Proteínas Bacterianas/genética , Clonación Molecular , ADN/química , ADN/genética , Daño del ADN , Reparación del ADN , Proteínas de Unión al ADN/fisiología , Electroforesis en Gel de Campo Pulsado , Exonucleasas/metabolismo , Eliminación de Gen , Genoma , Mitomicina/farmacología , Modelos Genéticos , Datos de Secuencia Molecular , Mutación , Plásmidos/metabolismo , Unión Proteica , ARN Mensajero/metabolismo , Radiación Ionizante , Recombinación Genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA